行情

PSTV

PSTV

Plus Therapeutics Inc
NASDAQ

实时行情|Nasdaq Last Sale

2.710
-0.010
-0.37%
盘后: 2.880 +0.17 +6.27% 18:56 01/17 EST
开盘
2.750
昨收
2.720
最高
2.860
最低
2.680
成交量
8.38万
成交额
--
52周最高
24.45
52周最低
1.780
市值
1,021.83万
市盈率(TTM)
-0.1420
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

PSTV 新闻

  • 英国诺丁汉市开始试验无线充电的出租车
  • TechWeb.3小时前
  • FBI探员力挺苹果:已经为调查提供足够帮助
  • 新浪科技.3小时前
  • 亚马逊手掌支付进行终端测试 Visa等成合作伙伴
  • 新浪科技.4小时前
  • 又是波音 日航一架客机起飞前驾驶室挡风玻璃开裂
  • 中国新闻网.4小时前

更多

所属板块

生物技术和医学研究
-0.16%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

PSTV 简况

Plus Therapeutics, Inc., formerly Cytori Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers. The Company is focused on developing generic oncology drugs that address unmet medical and market needs. The Company’s lead product candidate, DocePLUS, is an albumin-stabilized PEGylated liposomal formulation of docetaxel. DocePLUS is developed for the treatment of patients with small cell lung cancer (SCLC). The Company is also developing DoxoPLUS, which is a generic PEGylated liposomal formulation of doxorubicin. DoxoPLUS is developed for the treatment of breast cancer, ovarian cancer, multiple myeloma and Kaposi’s sarcoma.
展开

Webull提供Plus Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。